Osiris Therapeutics, Inc. (NASDAQ: OSIR)

Osiris Therapeutics, Inc. (NASDAQ: OSIR), a leading stem cell therapeutic company, has their focus on developing and marketing products for the treatment of medical conditions in the inflammatory, orthopedic, and cardiovascular areas. The company’s stem cell products have major therapeutic potential because of their ability to promote tissue regeneration, regulate inflammation and prevent pathological scar formation. For further information, visit the Company’s web site at www.osiris.com.